Nektar Therapeutics
NKTR
NKTR
358 hedge funds and large institutions have $16.7B invested in Nektar Therapeutics in 2018 Q1 according to their latest regulatory filings, with 127 funds opening new positions, 89 increasing their positions, 124 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
29% more funds holding in top 10
Funds holding in top 10: 14 → 18 (+4)
0.05% less ownership
Funds ownership: 6.56% → 6.51% (-0.05%)
28% less repeat investments, than reductions
Existing positions increased: 89 | Existing positions reduced: 124
Holders
358
Holding in Top 10
18
Calls
$355M
Puts
$168M
Top Buyers
| 1 | +$1.37B | |
| 2 | +$257M | |
| 3 | +$249M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$157M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$154M |
Top Sellers
| 1 | -$740M | |
| 2 | -$413M | |
| 3 | -$351M | |
| 4 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$197M |
| 5 |
Primecap Management
Pasadena,
California
|
-$138M |